Rpg Life Sciences Limited · NSE:RPGLIFE
Rpg Life Sciences — Investor Presentation (September 2026)
8 slides from Rpg Life Sciences's investor presentation, Sep 2, 2026
Slide 1: Cover letter to stock exchanges: Investors Presentation
September 2, 2026 National Stock Exchange of India Limited BSE Limited Plot No. C/1, “G” Block, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 051 Mumbai 400 001 Symbol: RPGLIFE Security Code: 532983 Dear Sirs, Sub: Investors Presentation In
Slide 2: RPG Active Pharma – Transaction Update
RPG Life Sciences RPG Active Pharma – Transaction Update 02nd September, 2026
Slide 3: Subsidiarization of API business into RPGAP for strategic focus
A Subsidiarization of API business into RPGAP for strategic focus API business • The API business operates from state-of-the-art Promoters Public Shareholders facility located at Navi Mumbai • Focused on high-value low-volume niche products which ware fairly insulated from price 72.95% 27.05% commod
Slide 4: Partnership with pharma-centric PE firm InvAscent for value creation
B Partnership with pharma-centric PE firm InvAscent for value creation Invascent (Investor) • InvAscent is one of India’s most specialised pharma-centric Private Equity firm bringing in over 20 years of experience of building businesses in formulations, API, healthcare RPGLS Investor delivery, medte
Slide 5: Acquisition of Actis Generics by RPGAP for enhancing Product Portfolio
C Acquisition of Actis Generics by RPGAP for enhancing Product Portfolio Actis Generics • Actis is a fully backward-integrated RPGLS Investor manufacturer of API and complex intermediates based out of Vizag (AP) 60% 40% • Manufacturing facility is in Visakha Pharma City which provides all the benefi
Slide 6: Acquisition of Raghava Life Sciences for enhancing Capacity and Product Portfolio
D Acquisition of Raghava Life Sciences for enhancing Capacity and Product Portfolio Raghava Life Sciences RPGLS Investor • State-of-the-art manufacturing facility located close to Hyderabad spread over 9 Acres and a large installed capacity of 300 KL. 60% 40% • The facility is maintained impeccably
Slide 7: RPG Active Pharma – strategic readiness in all aspects for future growth
RPG Active Pharma – strategic readiness in all aspects for future growth • Niche products with strong • Partnered with pharma demand outlook focussed Investor • Stringent product selection • Sharper focus on API, criteria for high margin focus industry connects Product Partnership • R&D focus with n
Slide 8: Thank You
THANK YOU L RPG LIFE SCIENCES
RPG Life Sciences — Investor Presentation (September 2026) on 6ix